Navigation Links
Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
Date:1/29/2008

s the ultrasound circuitry and connects via a USB-2 interface. Features of the system include:

-- Large image display providing easy visualization of targeted vessels

and surrounding anatomy

-- Touchscreen display with intuitive and straightforward user interface

-- Scan operation controls on the probe itself allowing maintenance of

sterile field

-- Visualization of depth to 6cm with excellent resolution and accuracy

-- Software tools including calipers for measuring vessel size and needle

guide overlay to provide direction to intended vessel

Mr. O'Donnell added, "The timing of the VascuView(TM) introduction is key, as clinicians continue to adopt the use of ultrasound as a standard of care and technique for vascular access to ensure efficacy and reduce complications. The addition of the VascuView(TM) Visual Ultrasound System to our existing PD Access(TM) and SmartNeedle(TM) Doppler Ultrasound Guided Needles, allows Escalon Vascular Access to offer a complete product line for assisted vascular access needs."

Escalon Vascular Access specializes in the design, manufacture and distribution of instruments for assisted vascular access, including the PD Access(TM) and SmartNeedle(TM) Doppler-guided vascular access assemblies, which are used to locate desired vessels for access. These patented devices utilize a miniature Doppler ultrasound probe that is positioned within the lumen of a needle. When a Doppler-guided needle is inserted subcutaneously, the probe and monitor can differentiate when an artery or vein is approaching and guide successful access. The devices are distributed worldwide and used across several specialty groups including cardiac catheterization labs, intensive and critical care units, and interventional radiology.

Founded in 1987, Escalon develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
2. Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 2013 On average, developing a new ... billion dollars. Despite this investment, less than 10% of ... is your clinical trial design optimally structured to balance ... , Dr. Frederic Sax, Global Head of the Center ... of data, information and technology in upfront clinical trial ...
(Date:5/16/2013)... , May 16, 2013 /PRNewswire/ ... market research report is available in ... Diagnostic Cardiac Biomarkers for Acute Coronary ... Forecasts http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... for Acute Coronary Syndromes - APAC ...
(Date:5/16/2013)... May 16, 2013 DNA Genotek, a leading ... for Africa’, a sponsorship program in conjunction with the African ... to improve access and reduce the cost of DNA ... as the Human Heredity and Health in Africa (H3 Africa) ... , The aim of the AfSHG is to ...
(Date:5/16/2013)... A number of residents in an apartment complex ... from abcactionnews.com, it was no thanks to the infestation of ... recommended to the management and everyone else suffering from the ... the public to try samples of it to prove it ... 11, 2013 determined that the complex invaded by ...
Breaking Biology Technology:Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 2Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 3
... 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) ... of 6,700,000 shares of its common stock at a price ... is expected to close on or around Wednesday, April 13, ... the sole book-running manager in this offering and Sangamo has ...
... RICHMOND, Calif., April 7, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... to sell 6,700,000 shares of its common stock pursuant to ... Barclays Capital Inc. is the sole book-running manager in this ... day option to purchase up to 1,005,000 additional shares. ...
... The Center for Business Intelligence (CBI) announced today that ... in support of the relief efforts in Japan following a ... the fund while the organization matched employee donations. ... employees have displayed to help a nation in a desperate ...
Cached Biology Technology:Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... MD (May 18, 2013) The AGA Research Foundation ... into the relationship between the gut microbiota, one of ... and disease. , The AGA Research Awards Panel ... from Massachusetts General Hospital and Harvard Medical School, Boston, ... recipient. Dr. Chan will receive $25,000 of funding, commencing ...
(Date:5/17/2013)... celebrate the science and technology of the region ... the inaugural Atlanta Science Festival, March 22-29, 2014. ... corporations, K-12 schools and universities, the festival will ... and adults at venues across the city. Learn ... annual Atlanta Science Festival is a collaboration of ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2
... Brook University Medical Center in New York have confirmed that ... and not a descendant of healthy humans dwarfed by disease. ... female specimen, researchers determined the "hobbit" to be a distinct ... Details of the study appear in the December issue ...
... advance with overtones of Star Trek phasers and other sci-fi ... internal on-off "switch" that paralyzes animals when exposed to a ... the light is turned off. When exposed to ordinary light, ... in the Journal of the American Chemical Society ...
... using human saliva to tell whether those stiff joints, memory ... red flags for disease, scientists are describing how the protein ... could lead to a simple, noninvasive test for better diagnosing ... a report in ACS, Journal of Proteome Research , ...
Cached Biology News:'Hobbits' are a new human species -- according to the statistical analysis of fossils 2
... are macroporous polystyrene beads for hydrophobic interaction ... for adsorbing organics of molecular weight less ... are useful for the adsorption of nonpolar ... the removal of detergents such as Triton ...
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)...
... Phosphatase 2 (LPP2) fractionated ... solution Solution in ... 0.08% sodium azide. unique ... human LPP2 protein. The ...
Rabbit polyclonal to Retinoic Acid Receptor beta 2 ( Abpromise for all tested applications). entrezGeneID: 5915...
Biology Products: